Scientific Sessions 2024  /  Featured Science: Vascular Outcomes in the Spotlight  /  Evolution of Novel Therapies in Vascular Medicine
Logo

American Heart Association

  9
  0

Final ID:

Evolution of Novel Therapies in Vascular Medicine

  • Creager, Mark  ( Dartmouth-Hitchcock , Lebanon , New Hampshire , United States )
  • Beckman, Joshua  ( UT Southwestern , Dallas , Texas , United States )
    • Author Disclosures:
    Mark Creager: DO NOT have relevant financial relationships | Joshua Beckman: DO have relevant financial relationships ; Consultant:Janssen:Past (completed) ; Consultant:Merck:Active (exists now) ; Consultant:Antidote Therapeutics:Active (exists now) ; Consultant:Mingsight:Active (exists now) ; Consultant:JanOne:Active (exists now) ; Consultant:Novartis:Active (exists now)
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

Featured Science: Vascular Outcomes in the Spotlight

Monday, 11/18/2024 , 08:00AM - 09:15AM

Featured Science

More abstracts on this topic:
Discussant

Hamburg Naomi

Geographical variations of treatment disparities between Black and White patients with peripheral artery disease across the United States

Vogel Birgit, Erim Daniel, Pylypchuk Yuriy, Keever Rachel, Mehran Roxana, Dangas Katerina, Di Muro Francesca Maria, Sartori Samantha, Oliva Angelo, Dangas George, Krishnan Prakash, Yoon Harrison, Etter Katherine

More abstracts from these authors:
Rural and Urban Patterns of Monitoring of Implanted Cardiac Devices in the US

Zeitler Emily, Zhou Weiping, Creager Mark, O'malley James

Antithrombotic prophylaxis in patients with peripheral arterial disease

Bonaca Marc, Creager Mark

You have to be authorized to contact abstract author. Please, Login
Not Available